Form 10-Q NEUROCRINE BIOSCIENCES For: Jun 30
Tweet
Share
E-mail
http://archive.fast-edgar.com/20140806/A82VB22EZZ2RJ2ZZ2HZO2WXR2EQQZZ22Z26Q
Filed on: August 6, 2014
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Neurocrine's Ingrezza study shows quality-of-life gains in TD patients
- NetworkNewsBreaks – Greenland Energy Company (NASDAQ: GLND) Targets Winter 2027 Permit Timeline for Greenland Project
- Neurocrine Biosciences Announces Publication of KINECT-PRO™ Findings Demonstrating INGREZZA® (valbenazine) Capsules Improved Patient-Reported Quality of Life and Daily Functioning for People Living
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
